Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 12 studies | 53% ± 24% | |
GABAergic neuron | 9 studies | 48% ± 24% | |
amacrine cell | 7 studies | 29% ± 6% | |
neuron | 6 studies | 28% ± 8% | |
interneuron | 6 studies | 51% ± 26% | |
oligodendrocyte precursor cell | 6 studies | 21% ± 6% | |
retinal ganglion cell | 5 studies | 31% ± 14% | |
retina horizontal cell | 5 studies | 27% ± 6% | |
granule cell | 4 studies | 30% ± 8% | |
GABAergic interneuron | 3 studies | 44% ± 9% | |
rod bipolar cell | 3 studies | 19% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 12 studies | 38% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 6148.84 | 2610 / 2642 | 90% | 9.88 | 635 / 705 |
adrenal gland | 95% | 1260.55 | 245 / 258 | 77% | 15.77 | 176 / 230 |
ovary | 98% | 2892.84 | 176 / 180 | 25% | 0.73 | 108 / 430 |
prostate | 51% | 445.42 | 125 / 245 | 57% | 1.47 | 288 / 502 |
uterus | 31% | 221.56 | 53 / 170 | 12% | 0.39 | 56 / 459 |
esophagus | 26% | 219.34 | 382 / 1445 | 9% | 0.23 | 17 / 183 |
stomach | 25% | 266.67 | 89 / 359 | 9% | 0.35 | 25 / 286 |
intestine | 17% | 122.77 | 169 / 966 | 4% | 0.11 | 21 / 527 |
pancreas | 0% | 0 | 0 / 328 | 21% | 0.96 | 38 / 178 |
lung | 0% | 0 | 0 / 578 | 15% | 0.54 | 169 / 1155 |
heart | 9% | 61.75 | 81 / 861 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 8% | 0.40 | 31 / 406 |
thymus | 0% | 0 | 0 / 653 | 6% | 0.12 | 36 / 605 |
bladder | 0% | 0 | 0 / 21 | 5% | 0.11 | 25 / 504 |
breast | 2% | 8.64 | 7 / 459 | 3% | 0.07 | 32 / 1118 |
eye | 0% | 0 | 0 / 0 | 3% | 0.07 | 2 / 80 |
skin | 0% | 0.85 | 2 / 1809 | 2% | 0.05 | 8 / 472 |
kidney | 0% | 0 | 0 / 89 | 1% | 0.03 | 9 / 901 |
blood vessel | 0% | 0.79 | 2 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1904717 | Biological process | regulation of AMPA glutamate receptor clustering |
GO_0099072 | Biological process | regulation of postsynaptic membrane neurotransmitter receptor levels |
GO_0051966 | Biological process | regulation of synaptic transmission, glutamatergic |
GO_1900449 | Biological process | regulation of glutamate receptor signaling pathway |
GO_0005575 | Cellular component | cellular_component |
GO_0045202 | Cellular component | synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0045505 | Molecular function | dynein intermediate chain binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | FRRS1L |
Protein name | DOMON domain-containing protein FRRS1L (Brain protein CG-6) (Ferric-chelate reductase 1-like protein) Ferric chelate reductase 1 like |
Synonyms | C9orf4 |
Description | FUNCTION: Important modulator of glutamate signaling pathway. . |
Accessions | A0A2R8Y5Y6 ENST00000644747.1 ENST00000642299.1 A0A2R8YDG8 ENST00000644736.1 Q9P0K9 ENST00000561981.5 A0A2R8Y4E4 |